Key statistics dashboard for None (SRTS). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy.
Stock Data
| Price | $3.07 |
| Market Cap | $51M |
| Beta | 1.28 |
Valuation Multiples
| P/E Ratio | -3.32 |
| Price / Book | 1.39 |
| P/S | 2.92 |
| P/FCF | -7.36 |
Profitability
| Gross Margin | 36.39% |
| EBIT Margin | -56.45% |
| EBITDA Margin | -54.26% |
| Operating Margin | -75.72% |
| Net Margin | -88.45% |
Financial Health
| Current Ratio | 8.71 |
| Quick Ratio | 4.44 |
| Cash Ratio | 3.51 |
| Debt / Equity | 0.01 |
| Debt / Assets | 0.83% |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 8.85 |
Per-Share Data
| Revenue per share | 1.06 |
| Book Value per share | 2.24 |
| Cash per share | 0.92 |
| FCF per share | -0.42 |
| Tangible Book Value per share | 2.24 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 6 |
| Hold | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 9 |
| Avg rating (1-5) | 0.67 |